Neurohypophysial peptides design of tissue-specific agonists and antagonists (Q40124914)

17 September 2017

1 reference

title

Neurohypophysial peptides. Design of tissue-specific agonists and antagonists (English)

1 reference

17 September 2017

Neurohypophysial peptides design of tissue-specific agonists and antagonists (English)

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

10 September 2023

W. H. Sawyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6263733

10 September 2023

Z. Grzonka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6263733

10 September 2023

M. Manning

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6263733

10 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6263733

10 September 2023

publication date

1 May 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0303720781900861?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

https://api.elsevier.com/content/article/PII:0303720781900861?httpAccept=text/plain

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Molecular and Cellular Endocrinology

10 September 2023

published in

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

117-134

1 reference

Journal of Pharmacology and Experimental Therapeutics

17 September 2017

cites work

193

413

Altura

1975

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Design of potent antagonists of the vasopressor response to arginine-vasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues)

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The syndrome of inappropriate secretion of antidiuretic hormone

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Vasopressin analogues with selective pressor activity

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and biological activities of arginine-vasopressin analogs designed from a conformation-activity approach

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

10 September 2023

Molecular Pharmacology

1006

Butlen

1978

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Journal of Pharmacology and Experimental Therapeutics

10 September 2023

196

746

Chan

1976

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Journal of Pharmacology and Experimental Therapeutics

10 September 2023

174

541

Chan

1970

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Journal of Pharmacology and Experimental Therapeutics

10 September 2023

156

150

Chan

1967

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Some Pharmacologic Studies on 1-L-Penicillamine-oxytocin and 1-Deaminopenicillamine-oxytocin: Two Potent Oxytocin Inhibitors1

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Evidence and quantification of the vasopressin arterial pressure control system in the dog

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The Synthesis of Oxytocin1

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

(1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and pharmacological properties of 4-decarboxamido-8-arginine-vasopressin and its 1-deamino analog

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

1,6-Aminosuberic acid analogs of lysine- and arginine-vasopressin and -vasotocin. Synthesis and biological properties

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

1-(L-2-Hydroxy-3-mercaptopropanoic acid)-oxytocin, a highly potent analogue of oytocin not bound by neurophysin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The action of 2-O-Methyltyrosine-oxytocin on the rat and rabbit uterus: effect of some experimental conditions on change from agonism to antagonism

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiu

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

1-(L-2-hydroxy-3-mercaptopropanoic acid) analogues of arginine-vasopressin, 8-D-argininevasopressin, and 4-valine,8-D-argininevasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

1-(.beta.-Mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),4-valine, 8-D-argininevasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthetic antagonists of in vivo responses by the rat uterus to oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Solid-phase synthesis of [4-threonine]-oxytocin. More potent and specific oxytocic agent than oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The deamino derivatives of [4-threonine]-oxytocin and [4-threonine]-mesotocin; Analogs possessing a surprising spectrum of diminished pharmacological activities

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Solid-phase synthesis and some pharmacological properties of 4-threonine analogs of vasopressins and vasotocin and of arginine-vasopressin and arginine-vasotocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Solid-phase synthesis and some pharmacological properties of deamino-4-threonine analogs of the vasopressins and vasotocin and [deamino]arginine-vasotocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hy

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

[1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

1-.beta.-Mercapto-.beta.,.beta.-pentamethylenepropionic acidoxytocin, a potent inhibitor of oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Tentative Identification of Arginine Vasotocin in Human Cerebrospinal Fluid

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Vasotocin biosynthesis by cultured pineal glands from adult male rats

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

4-Threonine analogues of neurohypophysial hormones withh selectively enhanced oxytocin-like activities

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Structural Changes in the Arginine Vasopressin Molecule that Enhance Antidiuretic Activity and Specificity1

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Structural Changes in the Arginine Vasopressin Molecule that Prolong Its Antidiuretic Action

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

The design of effective in vivo antagonists of rat uterus and milk ejection responses to oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

British Journal of Pharmacology

10 September 2023

189

Schild

1947

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis of 1-L-penicillamine-oxytocin, 1-D-penicillamine-oxytocin, and 1-deaminopenicillamine-oxytocin, potent inhibitors of the oxytocic response of oxytocin

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis of deaminooxytocin by the solid phase method

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Journal of Pharmacology and Experimental Therapeutics

10 September 2023

188

241

Vávra

1974

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Synthesis of three oxytocin analogs related to [1-deaminopenicillamine]oxytocin prossessing antioxytocic activity

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones

10 September 2023

1 reference

https://api.crossref.org/works/10.1016/0303-7207(81)90086-1

10 September 2023

Identifiers

1 reference

17 September 2017

1 reference